Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

About the company

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

29

$0.00M

Total Revenue

29

Employees

$2B

Market Capitalization

-15.19

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Catalent, Inc. CTLT 11818.68 2872.00 5.94 113.31 3.63
Horizon Therapeutics Plc HZNP 11795.70 1376.00 5.03 18.60 43.06
Perrigo Co. Plc PRGO 7706.25 4837.00 1.32 52.57 3.02
Bausch Health Cos., Inc. BHC 6142.20 8597.00 8.57 -3.25 -21.96
Jazz Pharmaceuticals Plc JAZZ 6116.67 2188.00 2.11 22.36 12.81
United Therapeutics Corp. UTHR 5208.59 1443.00 1.81 10.05 36.59
MyoKardia, Inc. MYOK 4349.76 34.00 12.64 -14.03 -201.73
Axsome Therapeutics, Inc. AXSM 2779.70 None 18.86 -30.90 None
Pacira Biosciences, Inc. PCRX 2407.86 435.00 6.46 -5733.01 -0.02
SAGE Therapeutics, Inc. SAGE 2353.00 9.00 2.77 -3.63 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Prestige Consumer Healthcare, Inc. PBH 2006.85 963.00 1.69 14.15 14.77
Corcept Therapeutics, Inc. CORT 1989.82 335.00 4.57 18.75 31.64
Ironwood Pharmaceuticals, Inc. IRWD 1604.54 440.00 -22.71 18.93 19.14
Innoviva, Inc. INVA 1559.40 285.00 3.69 8.07 66.41
Madrigal Pharmaceuticals, Inc. MDGL 1551.15 0.00 4.14 -15.19 -624.74
Revolution Medicines, Inc. RVMD 1534.59 48.00 3.98 -21.68 -146.29
Intercept Pharmaceuticals, Inc. ICPT 1390.40 272.00 -41.38 -4.05 -127.53
Supernus Pharmaceuticals, Inc. SUPN 1346.76 402.00 2.14 11.55 28.90
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Theravance Biopharma, Inc. TBPH 1255.14 88.00 -8.81 -5.09 -280.80
Zogenix, Inc. ZGNX 1233.00 5.00 3.37 -2.90 -241.62
Revance Therapeutics, Inc. RVNC 1139.28 0.00 4.50 -6.11 41.82
Amphastar Pharmaceuticals, Inc. AMPH 993.23 327.00 2.48 19.49 15.90
BellRing Brands, Inc. BRBR 805.74 954.00 -0.44 6.11 13.98
Endo International Plc ENDP 775.20 3014.00 -1.06 -2.76 -9.09
Assembly Biosciences, Inc. ASMB 684.40 16.00 3.07 -6.88 -601.75
Eagle Pharmaceuticals, Inc. EGRX 679.42 192.00 3.65 269.61 1.29
Aerie Pharmaceuticals, Inc. AERI 632.04 79.00 5.01 -3.12 -252.92
Intersect ENT, Inc. XENT 591.04 102.00 5.58 -11.84 -48.61
Collegium Pharmaceutical, Inc. COLL 590.24 299.00 4.22 -45.68 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 541.42 119.00 5.27 12.34 36.09
Anika Therapeutics, Inc. ANIK 529.20 125.00 1.83 19.09 22.73
BioDelivery Sciences International, Inc. BDSI 391.92 130.00 5.61 -53.25 -5.01
ANI Pharmaceuticals, Inc. ANIP 341.64 203.00 1.75 -219.00 -0.67
Albireo Pharma, Inc. ALBO 309.92 11.00 3.15 -4.05 -730.55
MEI Pharma, Inc. MEIP 281.37 5.00 4.84 -7.21 -539.48
Mallinckrodt Plc MNK 231.00 3037.00 0.12 -0.19 -39.56
Agile Therapeutics, Inc. AGRX 149.86 None 2.44 -7.26 None
Cerecor, Inc. CERC 118.68 7.00 7.59 -5.27 -429.22
Marinus Pharmaceuticals, Inc. MRNS 116.87 0.00 5.30 -1.73 None
Ampio Pharmaceuticals, Inc. AMPE 97.24 1.00 68.00 -5.23 None
Evoke Pharma, Inc. EVOK 87.12 397.00 30.25 -12.96 -0.76
AcelRx Pharmaceuticals, Inc. ACRX 86.40 2.00 -1.59 -1.54 -644.25
Aclaris Therapeutics, Inc. ACRS 83.23 4.00 1.46 -0.60 None
Zynerba Pharmaceuticals, Inc. ZYNE 78.43 0.00 1.29 -2.19 -699.94
Adamas Pharmaceuticals, Inc. ADMS 77.56 57.00 -4.95 -0.84 -160.44
Oramed Pharmaceuticals, Inc. ORMP 77.14 3.00 2.80 -7.12 -398.34
CTI BioPharma Corp. CTIC 73.75 3.00 3.29 -1.79 -111.83
Cassava Sciences, Inc. SAVA 64.41 41.00 3.39 -14.13 76.71
Acasti Pharma, Inc. ACST 58.74 0.00 4.94 -2.30 -611.47
Cumberland Pharmaceuticals, Inc. CPIX 48.75 47.00 0.99 -10.83 -9.59
Natural Alternatives International, Inc. NAII 47.32 114.00 0.65 -12.52 -3.19
SCYNEXIS, Inc. SCYX 46.24 0.00 9.71 -1.19 -30.84
IsoRay, Inc. ISR 42.21 9.00 7.87 -12.60 -36.08
Lipocine, Inc. LPCN 36.90 0.00 8.79 -2.46 None
Neos Therapeutics, Inc. NEOS 31.92 65.00 -2.46 -1.82 -26.74
PLx Pharma, Inc. PLXP 25.29 0.00 -2.42 -2.68 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.64 3.00 2.57 -1.74 -264.21
Regulus Therapeutics, Inc. RGLS 16.17 0.00 1.43 -0.75 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.66 -0.15 -798.18
Intec Pharma Ltd. NTEC 11.25 None 1.45 -0.26 None
Hepion Pharmaceuticals, Inc. HEPA 10.17 None 1.79 3.05 None
Sonoma Pharmaceuticals, Inc. SNOA 6.77 19.00 1.53 -3.40 -15.56
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.72 73.00 -0.13 -0.19 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 3.96 None 0.99 -0.08 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Madrigal Pharmaceuticals Inc YDO1

6d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals

27d ago, source: The Motley Fool

Intercept Pharmaceuticals (NASDAQ:ICPT) and Madrigal Pharmaceuticals (NASDAQ:MDGL) are two stocks that have moved in opposite directions of late. Intercept's stock has slid by 36% since the year ...

Madrigal Pharmaceuticals Inc. Market Perform

1mon ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net Summary: Madrigal Pharmaceuticals Inc. Market Perform Analyst Opinions for Madrigal Pharmaceuticals Inc.More Latest ...

Non-alcoholic Steatohepatitis Market Set for Rapid Growth and Trend, by 2025

1mon ago, source: MarketWatch

The MarketWatch News Department was not involved in the creation of this content. Jun 10, 2020 (HTF Market Intelligence via COMTEX) -- AMA published a new study on the Global Non-alcoholic ...

Constellation Pharmaceuticals Announces Appointment of Dr. Richard Levy to Board of Directors

1mon ago, source: GlobeNewswire

April 06, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq ... Dr. Levy currently serves on the boards of Madrigal Pharmaceuticals, Kodiak Sciences, Kiniksa Pharmaceuticals ...

Madrigal Pharmaceuticals Inc.

7d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Madrigal Pharmaceuticals Inc MDGL

9d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.